Shionogi To Launch Non-pyrazolone Antipyretic Analgesic 揝ede

Shionogi & Co., Ltd. (Headquarters: Osaka, President: Motozo Shiono) announced that it will launch the non-pyrazolone antipyretic analgesic 揝edes 甐?with vitamin B1 on July 19, 2006.

In addition to its antipyretic and analgesic ingredients, Sedes 甐 contains the vitamin B1 derivative dicethiamine hydrochloride, which aids pain relief by relaxing muscles through improved lactic acid metabolism. It exhibits an analgesic effect on headaches associated with stiffness of the neck and other forms of tension headache, and replaces vitamin B1 lost during chills and fever.

Through the addition of Sedes 甐 as the fourth product in the Sedes?lineup, Shiongi aims to further develop the Sedes ?brand in the field of antipyretic analgesics in order to help individuals suffering from headaches, menstrual cramps, toothaches and other types of pain.

Product Overview

Active Ingredients (per tablet) Ethenzamide - 200mg Acetaminophen - 80mg Allylisopropylacetylurea - 30mg Anhydrous caffeine - 40mg Dicethiamine hydrochloride (vitamin B1 derivative) - 4mg

Indications

Headache, toothache, menstrual cramps, pain associated with stiffness of the neck, neuralgia, backache, pain from wounds, pain after tooth extraction, throat pain, earache, arthritis, muscle ache, pain associated with bruising, pain associated with fractures, pain associated with sprains, chills, fever

Directions / Dosage

Sedes 甐 is best taken after meals in the quantities indicated below with cool or lukewarm water. Time between doses should be four or more hours.

Adults (over 15)
Single Dose -2 tablets
3 doses per 24 hour period maximum

Children (from 7 to 15 years)
Single Dose - 1 tablet
3 doses per 24 hour period maximum

Children under 7 - Do not take

Packaging, Quantity, Suggested Retail Price
10 tablets: 420 yen
30 tablets: 945 yen (includes tax)

http://www.shionogi.co.jp/index_e.html
(责任编辑：泉水)

搜索

热门标签:

Shionogi To Launch Non-pyrazolone Antipyretic Analgesic 揝ede